Oppenheimer Maintains an 'Outperform' on HMS Holdings (HMSY); In-line Results with Plenty to Come
Tweet
Share
E-mailGet Alerts HMSY Hot Sheet
Price: $36.98 --0%
Rating Summary:
5 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer maintains an 'Outperform' on HMS Holdings (NASDAQ: HMSY) price target of $38.00.
Analyst, Bret Jones, said, "Shares of HMSY traded up ~9% after the company announced in-line 2Q12 results. We believe the market was reassured by in-line results, the company's reiteration of guidance, and commentary that the company could likely achieve guidance without additional new wins. With the company in implementation mode, we believe 2H12 is poised for a potential beat depending on the continued success of HDI/Medicare RAC. Additionally, HMS announced 6 more Medicaid RAC state wins in AK, ID, MT, UT, MN and VA, and we continue to believe the market is underestimating the Medicaid RAC opportunity. Last, management hinted at Healthcare Exchange revenue in 2013, which we see as upside."
FY12 EPS estimate raised by $0.01 to $0.63 and FY13 lowered by $0.01 to $0.91.
For an analyst ratings summary and ratings history on HMS Holdings click here. For more ratings news on HMS Holdings click here.
Shares of HMS Holdings closed at $34.35 yesterday.
Analyst, Bret Jones, said, "Shares of HMSY traded up ~9% after the company announced in-line 2Q12 results. We believe the market was reassured by in-line results, the company's reiteration of guidance, and commentary that the company could likely achieve guidance without additional new wins. With the company in implementation mode, we believe 2H12 is poised for a potential beat depending on the continued success of HDI/Medicare RAC. Additionally, HMS announced 6 more Medicaid RAC state wins in AK, ID, MT, UT, MN and VA, and we continue to believe the market is underestimating the Medicaid RAC opportunity. Last, management hinted at Healthcare Exchange revenue in 2013, which we see as upside."
FY12 EPS estimate raised by $0.01 to $0.63 and FY13 lowered by $0.01 to $0.91.
For an analyst ratings summary and ratings history on HMS Holdings click here. For more ratings news on HMS Holdings click here.
Shares of HMS Holdings closed at $34.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Sansera Engineering Ltd (SANSERA:IN) PT Raised to INR4,250 at ICICI Securities
- Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
